The effect of series A preferred dividends on net loss per share calculation.

No definition available.

Name:	fbio_EffectOfSeriesPreferredDividendsOnNetLossPerShareCalculation
Namespace Prefix:	fbio_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The effect of subsidiaries deemed dividends on net income (loss) per share calculation.

+ References

No definition available.

+ Details

Name:	fbio_EffectOfSubsidiaryDeemedDividendsOnNetIncomeLossPerShareCalculation
Namespace Prefix:	fbio_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

+ Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=fbio_UnvestedRestrictedStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=fbio_UnvestedRestrictedStockUnitsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Net Income (Loss) per Common Share (Schedule of potentially dilutive securities) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Antidilutive Securities Excluded from Computation of Earnings Per Share
Effect of Series A preferred dividends on net income (loss) per share calculation	$ 2,000	$ 2,000	$ 4,000	$ 4,000
Effect of subsidiaries deemed dividends	$ 0	$ 100	$ 0	$ 200
Potentially dilutive securities			9,324,678	20,077,787
Warrants to purchase Common Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share
Potentially dilutive securities			5,951,817	14,309,001
Options to purchase Common Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share
Potentially dilutive securities				18,896
Unvested Restricted Stock and deferred Restricted Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share
Potentially dilutive securities			1,461,637	3,094,187
Unvested Restricted Stock units and deferred Restricted Stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share
Potentially dilutive securities			1,911,224	2,655,703